Skip to main content
CRYO CELL INTERNATIONAL INC logo

CRYO CELL INTERNATIONAL INC — Investor Relations & Filings

Ticker · CCEL ISIN · US2288951088 LEI · 254900AQWFD6AR2J7Z30 US Human health and social work activities
Open in API
Filings indexed 897 across all filing types
Latest filing 2021-09-22 Board/Management Inform…
Country US United States of America
Listing US CCEL

About CRYO CELL INTERNATIONAL INC

https://www.cryo-cell.com/

Cryo-Cell International, Inc. is a biotechnology company specializing in cellular processing and cryogenic storage. Established in 1989 as the world's first private cord blood bank, the company's primary service is the collection, processing, and long-term preservation of stem cells from umbilical cord blood and cord tissue. These services are offered to families for potential future use in treating a wide range of medical conditions. The company is focused on providing high-quality cryopreservation services and contributing to the advancement of regenerative medicine through its support of research and clinical applications.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 17, 2021. The key content includes the resignation of two directors and the appointment of two new directors to the Board of Cryo-Cell International, Inc. It also mentions the fixing of the date for the Annual Meeting of Stockholders and related procedural details. There are no financial statements or detailed financial data presented. The primary focus is on changes in the company's board of directors and related governance matters. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not an annual report, earnings release, or other financial report, nor is it a proxy statement or voting results announcement. Therefore, the correct classification is MANG with high confidence.
2021-09-22 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-15 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-01 English
Regulatory Filings 2021
Regulatory Filings
2021-08-30 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It details the description of the registrant's securities to be registered, including voting rights, dividend rights, liquidation rights, and other corporate governance provisions. This form is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to securities registration. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. Given the nature of the document as a registration statement filed with the SEC and its content, the appropriate classification is Regulatory Filings (RNS).
2021-08-27 English

Browse filings by year

30 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.